Advanced In Vivo Efficacy Models for Preclinical Success, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how in vivo PK/PD and efficacy models drive progress in oncology, immunology and fibrosis, with real-world case studies showcasing their successful applications. Attendees will gain insight into emerging trends in in vivo modeling and the use of translational toolkits, including patient-derived xenograft (PDX) and humanized models. The featured speakers will share practical strategies to increase model relevance and improve clinical predictivity.

TORONTO, Aug. 6, 2025 /PRNewswire/ — A comprehensive portfolio of in vivo services plays a critical role in providing essential insights into drug behavior, efficacy and safety. This webinar will highlight how advanced pharmacokinetic/pharmacodynamic (PK/PD) and efficacy models are pivotal in advancing drug candidates from discovery through preclinical development.  

Focusing on three key therapeutic areas — oncology/immuno-oncology (IO), immunology and fibrosis — this webinar will share internal as well as customer-approved case studies that demonstrate how preclinical in vivo platforms have supported decision-making and accelerated program timelines. These case studies will be contextualized within the broader industry landscape, underscoring the growing need for predictive and scalable preclinical models.

Building on this foundation, this session will examine how validated and custom in vivo platforms are used to develop disease-relevant models that closely replicate human pathophysiology. Integrated PK/PD studies and biomarker analyses confirm mechanisms of action, while study designs are carefully tailored to meet clinical and regulatory objectives. Complemented by advanced analytics, such as digital histopathology, these approaches provide quantifiable insights, and a collaborative, science-driven process ensures efficient progression toward IND-enabling milestones.

Register for this webinar to explore how PK/PD and in vivo efficacy models can accelerate preclinical success across oncology, immunology, fibrosis and other therapeutic areas.

Join experts from Aragen Bioscience, Malavika Ghosh, PhD, Senior VP and Head, Global Preclinical Research Services; and Linh Nguyen, PhD, Director, Oncology & Immunology, Global Preclinical Research Services, for the live webinar on Tuesday, August 26, 2025, at 11am EDT (5pm CEST/EU-Central).

For more information, or to register for this event, visit Advanced In Vivo Efficacy Models for Preclinical Success.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/advanced-in-vivo-efficacy-models-for-preclinical-success-upcoming-webinar-hosted-by-xtalks-302523157.html

SOURCE Xtalks